Vertex Pharmaceuticals Aktie: Phase-3-Daten sorgen für Aufsehen
Charlotte, NC (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Truist:Der Truist-Analyst Joon Lee habe das Kursziel für die Aktie von Vertex Pharmaceuticals…
415,525€
-1,87%
Echtzeit-Aktienkurs Vertex Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Vertex Pharmaceuticals Inc. Aktie
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $492.38, representing a -1.36% change from its previous close.…
Sensation in der Nierenmedizin! Vertex feiert Studiendurchbruch und erobert neuen Milliardenmarkt!
Lange Zeit war Vertex Pharmaceuticals (VRTX) an der Wall Street fast ausschließlich als unangefochtener Pionier in der Mukoviszidose-Behandlung bekannt. Doch…
Vertex Pharmaceuticals Aktie: Neue Fantasie - Morgan Stanley erhöht Kursziel
Bad Marienberg (www.aktiencheck.de) - Vertex Pharmaceuticals: Warum Morgan Stanley jetzt sogar 596 USD für möglich hältBei Vertex Pharmaceuticals Inc. (ISIN:…
Vertex Pharmaceuticals Aktie: Neue Mega-Chance im Biotech-Sektor?
Bad Marienberg (www.aktiencheck.de) - Biotech-Paukenschlag: Jefferies startet Vertex Pharmaceuticals mit Rating "buy" – Kursziel 580 USD sorgt für AufsehenDie Biotech-Welt…
Vertex Pharmaceuticals Aktie: Milliardenchance durch IgAN-Therapie?
Charlotte (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von BofA Securities:Die Analysten von BofA bestätigen für die Aktie von Vertex Pharmaceuticals Inc. (ISIN:…
Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more
These are some of the stocks seeing the largest midday moves.…
NASDAQ-Top des Tages Vertex Pharmaceuticals: Povetacicept-Studie überzeugt - Aktie springt 8%!
Bad Marienberg (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktie an der Spitze im NASDAQ 100: Citi hebt Kursziel auf 585 USDDie aktuelle Vertex…
Vertex passes key test in quest to treat kidney diseases
Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial.…
Vertex Pharmaceuticals Aktie: RAINIER-Studie entfacht neue Fantasie - Kursziel jetzt bei 641 USD!
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von H.C. Wainwright & Co.:Die Analysten von H.C. Wainwright behalten für die Aktie von…
Stocks making the biggest moves premarket: Kohls, Caseys General Stores, Vertex Pharmaceuticals and more
These are the stocks posting the largest moves in early trading.…
Top Research Reports for Broadcom, AT&T & Vertex Pharmaceuticals
Broadcom rides AI chip momentum with VMware gains, while AT&T and Vertex navigate growth plans and key headwinds in latest…
Vertex Pharmaceuticals Aktie: Alles wartet auf Phase-3-Daten!
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Sanford C. Bernstein & Co:Bernstein habe das Kursziel für die Aktie von Vertex…
Vertex Pharmaceuticals Aktie vor Blockbuster-Chance? Nieren-Franchise im Fokus
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Oppenheimer:Die Analysten von Oppenheimer haben Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807, Ticker-Symbol:…
Vertex Pharmaceuticals Aktie: Starke RAINIER-Daten - Kursziel deutlich auf 590 USD erhöht!
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Cantor Fitzgerald:Die Analysten von Cantor Fitzgerald haben das Kursziel für Vertex Pharmaceuticals Inc.…
Vertex Pharmaceuticals (VRTX) Q4 Earnings Miss Estimates
Vertex (VRTX) delivered earnings and revenue surprises of -0.74% and +0.70%, respectively, for the quarter ended December 2025. Do the…
Vertex Pharmaceuticals Aktie: Neuer CEO setzt auf Innovation - aber keine Katalysatoren für den großen Sprung!
Great Falls (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von D.A. Davidson & Co.:D.A. Davidson & Co. habe das Kursziel für die Aktie…
Why Vertex Pharmaceuticals (VRTX) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…
Should You Buy Vertex Pharmaceuticals Before Feb. 12?
The next 12 months will be important for the drugmaker.…
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release
Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today
Vertex Pharmaceuticals (VRTX) reached $470.1 at the closing of the latest trading day, reflecting a -1.17% change compared to its…
Vertex Pharmaceuticals Aktie: Fokus auf Nieren-Franchise - Neue Coverage und deutliches Kursziel-Upgrade!
London (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Barclays:Die Analysten von Barclays stufen die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN:…
Vertex Pharmaceuticals Aktie: Pharma und Biotech im Aufwind - UBS hebt Ziel leicht an
Zürich (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von der UBS:Die Analysten der UBS stufen die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…
Vertex Pharmaceuticals Aktie: FDA-Hoffnung Povetacicept treibt Kursziel deutlich nach oben
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Evercore ISI:Der Analyst Cory Kasimov von Evercore ISI hat das Kursziel für die…
Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider
Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $467.35, signifying a +1.35% move from its prior days close.…
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Heres Why
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $438.92, representing a -2.36% change from its previous close.…
Vertex Pharmaceuticals Aktie: Bernstein hebt auf Outperform - Top-Biotech-Pick für 2026
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Sanford C. Bernstein & Co:Der Analyst William Pickering von Bernstein hat die Aktie…
Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $463.86, indicating a -1.24% shift from the previous trading…
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
Vertex Pharmaceuticals (VRTX) reached $469.68 at the closing of the latest trading day, reflecting a -2.99% change compared to its…
Vertex Pharmaceuticals: 2026/27 könnte zum Daten-Knall für die Aktie werden
Zürich (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse der UBS:UBS-Analyst Michael Yee habe die Coverage von Vertex Pharmaceuticals mit einer Kaufempfehlung ("buy"-Rating) und…
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $453.74, marking a -1.31% move from the previous day.…
Vertex Pharmaceuticals Aktie: Sorgt die Pipeline jetzt für den nächsten Schub?
Boston, MA (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Leerink Partners:Leerink habe das Kursziel für die Aktie von Vertex Pharmaceuticals Inc. (ISIN:…
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $449.52, denoting a -1.2% move from the…
Vertex Pharmaceuticals Aktie: Bullishes Update nach Labortour und Analystenmeeting
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Morgan Stanley:Die Analysten von Morgan Stanley stufen die Aktie von Vertex Pharmaceuticals Inc.…
Why Vertex Pharmaceuticals (VRTX) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…
Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?
The stock has fallen from a peak back in April.…
Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates
Vertex (VRTX) delivered earnings and revenue surprises of +5.49% and +1.14%, respectively, for the quarter ended September 2025. Do the…
Vertex Pharmaceuticals (VRTX) Stock Moves -1.23%: What You Should Know
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $417.21, denoting a -1.23% move from the…
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030
Vertex appears to be by far the better buy right now.…
Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $416.81, representing a +2.01% change from its previous close.…
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $407.9, denoting a -1.05% move from the…
Heres Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $414.86, representing a -1.49% change from its previous close.…
Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $403.3, indicating a -1.36% shift from the previous trading…
Vertex Pharmaceuticals Aktie: Die Schere zwischen Nasdaq Biotech und der Aktie geht weit auseinander
Paris (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von der BNP Paribas:Egmond Haidt, Analyst der BNP Paribas, nimmt die Aktie von Vertex Pharmaceuticals…
Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $408.85, representing a +1.15% change from its previous close.…
Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $385.74, indicating a +1.01% shift from the previous trading…
Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $381.87, denoting a +1.39% move from the…
Vertex Pharmaceuticals Aktie: Truist bleibt bei "buy" - doch warum sinkt das Kursziel_
Bad Marienberg (www.aktiencheck.de) - Truist bleibt bullish auf Vertex Pharmaceuticals – trotz Kurszielsenkung
Ein neues Kapitel in der spannenden Geschichte von…
Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue Estimates
Vertex (VRTX) delivered earnings and revenue surprises of +6.60% and +2.59%, respectively, for the quarter ended June 2025. Do the…